Jason Keyes, MBA
Executive Vice President and Chief Financial Officer
Jason Keyes, MBA, serves as the executive vice president and chief financial officer of BlossomHill Therapeutics. Prior to joining, Mr. Keyes served for over seven years as chief financial officer of Equillium, Inc. He has also served as chief financial officer of Orexigen Therapeutics, Inc. Over the course of his nearly 25-year career in the biotechnology industry, Mr. Keyes has also held various corporate finance and strategic planning roles at Amylin Pharmaceuticals, Inc., Amgen, Inc., and Baxter Healthcare Corporation. Mr. Keyes currently serves on the board of directors at Actuate Therapeutics, Inc., and previously served on the board of directors at Sesen Bio, Inc. Mr. Keyes received B.S. and M.S. degrees in engineering from Stanford University as well as an MBA from the Anderson School at UCLA.